This page reprints a manufacturer label. Everything below in quotation marks is copied from RenaKare Gel, published by FDA and retrieved on 2026-09-16. Nothing has been added, reworded or left out of the sections shown. It is the manufacturer’s label, reproduced as published.
This page reprints the FDA label for RenaKare Gel by Neogen Corporation-Mercer Rd, a potassium product labelled for dogs and cats. The sections below are copied from that label without change, with the set id and the date it was retrieved from DailyMed. 3 other stored labels carry the same active ingredient and are listed at the end.
The label
Product: RenaKare Gel. Manufacturer: Neogen Corporation-Mercer Rd. FDA Structured Product Label set id 4550c672-8c64-4eae-87a7-e9812904b2f7. Label effective 2024-01-23. Retrieved 2026-09-16 from the DailyMed animal label release, and readable on DailyMed.
Indications
For use as a potassium supplement in hypokalemic cats and dogs.
Dosage and Administration
Adult cats and dogs.....2 mEq/4.5 kg (½ tsp/10 lb) PO BID Kittens and puppies............Consult veterinarian Administer with food. Gel is highly palatable. Place small amount on animal’s nose or in mouth to initiate interest. Place gel on food or on animal’s paw thereafter. Dosage may be adjusted as necessary by the veterinarian. Store in a dry place at a temperature between 15°-30°C (59°-86°F). Keep container tightly closed. UPC 7 26087 09076 4 KEEP OUT OF REACH OF CHILDREN
Warnings
Do no administer in diseases where high potassium levels may be encountered, such as severe renal insufficiency or adrenal insufficiency.
Precautions
Use with caution in the presence of cardiac disease, particularly in digitalized patients or in the presence of renal disease. Manufactured for Neogen Corporation Lexington, KY 40511 859-254-1221 neogen.com PRINCIPAL DISPLAY PANEL - 5 oz Bottle NDC: 59051-9076-6 RenaKare™ Gel Potassium Gluconate CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian. NEOGEN® Vet Net Contents: 5 oz (142 g) RenaKare Gel 5oz (142 g)
Other labels for this ingredient
These labels are also stored for the same active ingredient. They are not identical to the one reprinted above, and each is listed by product and set id rather than merged with it.
- RenaKare Potassium Gluconate POTASSIUM GLUCONATE POTASSIUM CATION, Neogen Corporation-Mercer. Set id 43642434-ed10-49da-954b-a6306cb939de.
- RenaPlus Potassium Gluconate POTASSIUM GLUCONATE POTASSIUM CATION SILICON DIOXIDE, MWI/VetOne. Set id 90caffe1-92bc-4c8d-baee-486611a9cffa.
- RenaPlus Potassium Gluconate POTASSIUM GLUCONATE POTASSIUM CATION, MWI/VetOne. Set id 10e2e633-9bc5-41d7-89ab-a10a928e89ce.
FDA adverse event reports
The FDA Center for Veterinary Medicine publishes the adverse event reports it receives through openFDA. The counts below are the reports naming potassium as an active ingredient for each species this label names, as returned on 2026-09-16, coded by the VeDDRA reaction term the reporter chose. Reactions are counted per report, so one report can appear under several terms.
These are counts, not rates. Reporting is voluntary, the number of animals treated is not known, and a widely used product accumulates reports for that reason alone. A report records that an event followed a dose; it does not establish that the product caused it. The counts say nothing about how one product compares with another.
Dogs: 3,412 reports
| VeDDRA reaction term | Reports |
|---|---|
| Vomiting | 692 |
| Lethargy (see also Central nervous system depression in 'Neurological') | 520 |
| Lack of efficacy - NOS | 449 |
| Other abnormal test result NOS | 340 |
| Anorexia | 305 |
| Death by euthanasia | 300 |
| Diarrhoea | 290 |
| Elevated alanine aminotransferase (ALT) | 260 |
| Seizure NOS | 251 |
| Emesis | 224 |
| Death | 221 |
| Leucocytosis NOS | 214 |
| Decreased appetite | 210 |
| Not eating | 206 |
| Elevated serum alkaline phosphatase (SAP) | 193 |
Outcome as recorded by the reporter: Ongoing 1,345; Recovered/Normal 800; Outcome Unknown 699; Euthanized 299; Died 236; Recovered with Sequela 35.
Queries: reports, reactions, outcomes. Dataset: openFDA Animal and Veterinary Adverse Event Reports.
Cats: 1,336 reports
| VeDDRA reaction term | Reports |
|---|---|
| Vomiting | 294 |
| Lethargy (see also Central nervous system depression in 'Neurological') | 169 |
| Lack of efficacy - NOS | 147 |
| Diarrhoea | 145 |
| Anorexia | 144 |
| Death by euthanasia | 125 |
| Death | 118 |
| Weight loss | 116 |
| Not eating | 104 |
| Other abnormal test result NOS | 94 |
| Decreased appetite | 84 |
| Lethargy (see also Central nervous system depression in Neurological) | 84 |
| Ataxia | 81 |
| Dehydration | 80 |
| Lack of efficacy (bacteria) - NOS | 80 |
Outcome as recorded by the reporter: Ongoing 464; Outcome Unknown 348; Recovered/Normal 265; Died 126; Euthanized 125; Recovered with Sequela 7.
Queries: reports, reactions, outcomes. Dataset: openFDA Animal and Veterinary Adverse Event Reports.
Sources
- RenaKare GelFDA · retrieved 2026-09-16
“Adult cats and dogs.....2 mEq/4.5 kg (½ tsp/10 lb) PO BID Kittens and puppies............Consult veterinarian Administer with food.” (Dosage and Administration)
- openFDA Animal and Veterinary Adverse Event ReportsFDA · retrieved 2026-09-16
Related
From Glarda
The note drafted from the consult, with the reference you just read sitting beside it in the shape your record already expects.